Aptahem strengthens the company’s management team with the appointment of a new Chief Medical Officer in advance of the clinical program
2018-02-27
Aptahem AB (publ) is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation are involved in the disease process. Aptahem is today pleased to announce the appointment...
Read More